港島Journal Watch 第1回

＜2012年1月分＞（担当　瀬尾）
１．Effect of intravenous β-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome(BALTI-2): a multicentre, randomised controlled trial

Lancet 2012; 379: 229–35 (PMID: 22166903)

ARDS患者にβ刺激薬静注は効果なし

２．Dicision Support Tool for Early Differential Diagnosis of Acute Lung Injury and Cardiogenic Pulmonary Edema in Medical Critically Ill Patients

Chest 2012; 141(1): 43–50 (PMID: 22030803)

スコアリングにてALIと肺うっ血の鑑別がサポートできるかも

３．Enoxaparin followed by once-weekly idrabiotaparinux versus enoxaparin plus warfarin for patients with acute symptomatic pulmonary embolism: a randomised, double-blind, double-dummy, non-inferiority trial

Lancet 2012; 379: 123–29 (PMID: 22130488)

急性肺塞栓症の長期管理に長時間作用型LMWHがワーファリンと同等の効果

４．Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial

Lancet 2012; 379: 229–35 (PMID: 22166903)

カテーテルによるDVT融解療法は2年間の症状抑制効果あり

５．β-Lactam/β-Lactam Inhibitor Combinations for the Treatment of Bacteremia Due to Extended-Spectrum β-Lactamase–Producing Escherichia coli: A Post Hoc Analysis of Prospective Cohorts

Clin Infect Dis 2012. ;54(2):167-74 (PMID: 22057701)

ESBL産生大腸菌菌血症に対するβラクタム/βラクマーゼ阻害剤は効くかも

2012年1月に抽出した全ての論文
https://docs.google.com/spreadsheet/ccc?key=0Av5LXNQSn1HDdGN2SEl3bmFhbkdpcHpxTzdXRGdsdUEdocs.google.com